RAI helps treat thyroid cancer by destroying any remaining cancer cells after the removal of the thyroid gland.
The thyroid gland absorbs nearly all of the iodine circulating systemically in the body. As a result, when RAI is administered in patients, it has the targeted ability to concentrate in and kill thyroid cells, including any residual thyroid cancer cells. For remnant ablation with RAI to be effective, patients must have sufficient levels of thyroid-stimulating hormone (TSH or thyrotropin) in the blood. This hormone stimulates any remaining thyroid tissue to take up the RAI.
However, with high TSH levels, patients often report that symptoms of hypothyroidism can affect their ability to manage many day-to-day responsibilities. In just one example, a recent study of cognitive and motor impairment in patients with hypothyroidism concluded that complex activities requiring rapid responses, such as operating motor vehicles, should be avoided during severe iatrogenic hypothyroidism.4 In recent years, management of the remnant ablation process using RAI has increasingly focused on strategies to help reduce the risk of hypothyroidism.
I can’t even imagine trying to function with my TSH that high, so I am glad to hear they are working on reducing that risk. Here is the full story:
We have all heard about the alarming rise in thyroid cancer diagnosis, so here are 4 signs of cancer you need to pay attention to:
With all the negative news about thyroid cancer and thyroid removal, here is some good news:
With all the thyroid cancer news this week, I included this reference article; it will explain the basics you need to know.